Payment overview · 2025
General Payments
$12.44
1 reported records · 1 companies
Healthcare provider profile · identity verified
Andrew Jon Kopperud, MD
Allopathic & Osteopathic Physicians|Internal Medicine · WESTBROOK, MN · NPI 1629294533
Verified facts
What the public records show
CMS Open Payments records show Andrew Jon Kopperud, MD received $12.44 in general payments during 2025 across 1 reported records.
Phathom Pharmaceuticals, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $12.44 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $12.44 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $12.44 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 383 | 66 |
| Amlodipine Besylate | Amlodipine Besylate | 355 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 354 | 45 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 337 | 72 |
| Omeprazole | Omeprazole | 334 | 68 |
| Lisinopril | Lisinopril | 295 | 57 |
| Metoprolol Succinate | Metoprolol Succinate | 279 | 53 |
| Gabapentin | Gabapentin | 242 | 36 |
| Losartan Potassium | Losartan Potassium | 231 | 40 |
| Furosemide | Furosemide | 210 | 39 |
| Tamsulosin Hcl | Tamsulosin Hcl | 207 | 44 |
| Hydrochlorothiazide | Hydrochlorothiazide | 172 | 38 |
| Metformin Hcl | Metformin Hcl | 163 | 35 |
| Xarelto | Rivaroxaban | 163 | 17 |
| Potassium Chloride | Potassium Chloride | 161 | 27 |
| Simvastatin | Simvastatin | 151 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 149 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 144 | 20 |
| Clopidogrel | Clopidogrel Bisulfate | 139 | 28 |
| Eliquis | Apixaban | 131 | 17 |
| Trazodone Hcl | Trazodone Hcl | 124 | 20 |
| Escitalopram Oxalate | Escitalopram Oxalate | 121 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 112 | 21 |
| Atenolol | Atenolol | 110 | 24 |
| Finasteride | Finasteride | 108 | 16 |
| Allopurinol | Allopurinol | 105 | 22 |
| Oxycontin | Oxycodone Hcl | 100 | suppressed |
| Famotidine | Famotidine | 99 | 19 |
| Buspirone Hcl | Buspirone Hcl | 98 | 14 |
| Jantoven | Warfarin Sodium | 98 | 18 |
| Oxycodone Hcl | Oxycodone Hcl | 92 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 90 | 20 |
| Metformin Hcl Er | Metformin Hcl | 89 | 18 |
| Sertraline Hcl | Sertraline Hcl | 89 | 14 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 87 | 13 |
| Glipizide | Glipizide | 85 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 80 | 11 |
| Montelukast Sodium | Montelukast Sodium | 78 | 12 |
| Lorazepam | Lorazepam | 77 | 16 |
| Alprazolam | Alprazolam | 76 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 76 | 15 |
| Carvedilol | Carvedilol | 75 | 13 |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 11 |
| Ezetimibe | Ezetimibe | 68 | 15 |
| Jardiance | Empagliflozin | 67 | 14 |
| Cephalexin | Cephalexin | 66 | 25 |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 65 | 63 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 64 | 14 |
| Donepezil Hcl | Donepezil Hcl | 59 | suppressed |
| Clonazepam | Clonazepam | 56 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 54 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 51 | 13 |
| Ondansetron Odt | Ondansetron | 50 | 13 |
| Ozempic | Semaglutide | 50 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 49 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 47 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 17 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 44 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 42 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 42 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 40 | suppressed |
| Trulicity | Dulaglutide | 40 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 39 | suppressed |
| Mirtazapine | Mirtazapine | 39 | suppressed |
| Tradjenta | Linagliptin | 39 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 39 | suppressed |
| Bupropion Xl | Bupropion Hcl | 38 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 38 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 38 | 27 |
| Januvia | Sitagliptin Phosphate | 37 | suppressed |
| Myrbetriq | Mirabegron | 37 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Amoxicillin | Amoxicillin | 36 | 18 |
| Bumetanide | Bumetanide | 36 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 35 | suppressed |
| Spironolactone | Spironolactone | 35 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 34 | suppressed |
| Prednisone | Prednisone | 34 | 20 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 34 | suppressed |
| Sucralfate | Sucralfate | 33 | suppressed |
| Carisoprodol | Carisoprodol | 32 | suppressed |
| Aripiprazole | Aripiprazole | 31 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 31 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 31 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 30 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Calcitriol | Calcitriol | 28 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 21 |
| Indapamide | Indapamide | 28 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 27 | suppressed |
| Meloxicam | Meloxicam | 27 | suppressed |
| Memantine Hcl | Memantine Hcl | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Cartia Xt | Diltiazem Hcl | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Cefdinir | Cefdinir | 25 | 14 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 25 | suppressed |
| Glipizide Er | Glipizide | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Levetiracetam | Levetiracetam | 24 | suppressed |
| Risperidone | Risperidone | 24 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 24 | suppressed |
| Ramipril | Ramipril | 23 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 22 | suppressed |
| Timolol Maleate | Timolol Maleate | 22 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 21 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 20 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 20 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 20 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 20 | suppressed |
| Digoxin | Digoxin | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 19 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Amantadine | Amantadine Hcl | 18 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 18 | 18 |
| Celecoxib | Celecoxib | 18 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Fenofibrate | Fenofibrate | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | 15 |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 17 | suppressed |
| Klor-Con M10 | Potassium Chloride | 17 | suppressed |
| Olanzapine | Olanzapine | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 16 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 16 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 15 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Diazepam | Diazepam | 14 | suppressed |
| Metolazone | Metolazone | 14 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 13 | suppressed |
| Fentanyl | Fentanyl | 13 | suppressed |
| Glimepiride | Glimepiride | 13 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 13 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 13 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 13 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 12 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 12 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Bevespi Aerosphere | Glycopyrrolate/Formoterol Fum | 12 | suppressed |
| Budesonide | Budesonide | 12 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Colesevelam Hcl | Colesevelam Hcl | 12 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 12 | suppressed |
| Klor-Con M20 | Potassium Chloride | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Topiramate | Topiramate | 12 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 12 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 12 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 11 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 11 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 11 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 11 | suppressed |
| Phenytoin | Phenytoin | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $12.44 · 1 records | Phathom Pharmaceuticals, Inc. | VOQUEZNA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error